Evidence map›Paper›PMID 28595603›Full record

ArticleMalaria journal2017

Current and cumulative malaria infections in a setting embarking on elimination: Amhara, Ethiopia.

Woyneshet G Yalew, Sampa Pal, Pooja Bansil, Rebecca Dabbs, Kevin Tetteh, Caterina Guinovart, Michael Kalnoky, Belendia A Serda, Berhane H Tesfay, Belay B Beyene and 8 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Using Serological Markers for the Surveillance ofPathogens (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 3 countries.

Woyneshet G YalewRegional Health Research Laboratory Center, Amhara National Regional State Health Bureau, P.O. Box 495, Bahir Dar, Ethiopia.
Sampa PalPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Pooja BansilPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Rebecca DabbsFaculty of Infectious and Tropical Diseases, London School of Tropical Medicine and Hygiene, Keppel Street, London, WCIE 7HT, UK.
Kevin TettehFaculty of Infectious and Tropical Diseases, London School of Tropical Medicine and Hygiene, Keppel Street, London, WCIE 7HT, UK.
Caterina GuinovartPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Michael KalnokyPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Belendia A SerdaPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Berhane H TesfayPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Belay B BeyeneRegional Health Research Laboratory Center, Amhara National Regional State Health Bureau, P.O. Box 495, Bahir Dar, Ethiopia.
Catherine SeneviratnePATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Megan LittrellPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Lindsay YokobePATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Gregory S NolandThe Carter Center, 453 Freedom Parkway, Atlanta, GA, 30307, USA.
Gonzalo J DomingoPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Asefaw GetachewPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Chris DrakeleyFaculty of Infectious and Tropical Diseases, London School of Tropical Medicine and Hygiene, Keppel Street, London, WCIE 7HT, UK.
Richard W SteketeePATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA. rsteketee@path.org.
Program for Appropriate Technology in Health · USUniversity of London · GBAmhara Regional Health Bureau · ETCarter Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince 2005, Ethiopia has aggressively scaled up malaria prevention and case management. As a result, the number of malaria cases and deaths has significantly declined. In order to track progress towards the elimination of malaria in Amhara Region, coverage of malaria control tools and current malaria transmission need to be documented.

methodsA cross-sectional household survey oversampling children under 5 years of age was conducted during the dry season in 2013. A bivalent rapid diagnostic test (RDT) detecting both Plasmodium falciparum and Plasmodium vivax and serology assays using merozoite antigens from both these species were used to assess the prevalence of malaria infections and exposure to malaria parasites in 16 woredas (districts) in Amhara Region.

results7878 participants were included, with a mean age of 16.8 years (range 0.5-102.8 years) and 42.0% being children under 5 years of age. The age-adjusted RDT-positivity for P. falciparum and P. vivax infection was 1.5 and 0.4%, respectively, of which 0.05% presented as co-infections. Overall age-adjusted seroprevalence was 30.0% for P. falciparum, 21.8% for P. vivax, and seroprevalence for any malaria species was 39.4%. The prevalence of RDT-positive infections varied by woreda, ranging from 0.0 to 8.3% and by altitude with rates of 3.2, 0.7, and 0.4% at under 2000, 2000-2500, and >2500 m, respectively. Serological analysis showed heterogeneity in transmission intensity by area and altitude and evidence for a change in the force of infection in the mid-2000s.

conclusionsCurrent and historic malaria transmission across Amhara Region show substantial variation by age and altitude with some settings showing very low or near-zero transmission. Plasmodium vivax infections appear to be lower but relatively more stable across geography and altitude, while P. falciparum is the dominant infection in the higher transmission, low-altitude areas. Age-dependent seroprevalence analyses indicates a drop in transmission occurred in the mid-2000s, coinciding with malaria control scale-up efforts. As malaria parasitaemia rates get very low with elimination efforts, serological evaluation may help track progress to elimination.

Indexed as

AdolescentAdultAgedAged, 80 and overAntigens, ProtozoanChildChild, PreschoolCoinfectionCross-Sectional StudiesEthiopiaFemaleHumansInfantMalariaMaleMerozoitesAntigens, ProtozoanMalariaMalaria transmissionPlasmodium falciparumPlasmodium vivaxSeroconversionSeroprevalence

Identifiers

PMID28595603
PMCPMC5465535
OpenAlexW2624389717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.